Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women

Weiling Leng,1 Danlan Pu,2 Juan Jiang,2 Xiaotian Lei,1 Qinan Wu,3,&ast; Bing Chen1,&ast; 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Departmen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Leng W, Pu D, Jiang J, Lei X, Wu Q, Chen B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	metformin breast density overweight/obese adiponectin Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/873a4ff2ab3d4d35a9441fc0d1fe15c6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:873a4ff2ab3d4d35a9441fc0d1fe15c6
record_format	dspace
spelling	oai:doaj.org-article:873a4ff2ab3d4d35a9441fc0d1fe15c62021-12-02T19:37:59ZEffect of Metformin on Breast Density in Overweight/Obese Premenopausal Women1178-7007https://doaj.org/article/873a4ff2ab3d4d35a9441fc0d1fe15c62021-11-01T00:00:00Zhttps://www.dovepress.com/effect-of-metformin-on-breast-density-in-overweightobese-premenopausal-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Weiling Leng,1 Danlan Pu,2 Juan Jiang,2 Xiaotian Lei,1 Qinan Wu,3,&ast; Bing Chen1,&ast; 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, People’s Republic of China; 3Endocrinology Department, Chongqing Medical University Affiliated Dazu Hospital, Dazu District People’s Hospital, Chongqing, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Qinan Wu; Bing Chen Email wqn11@126.com; chenbingxnyy@126.comBackground: This study investigated the effects of metformin on breast density in overweight/obese premenopausal women.Methods: Overweight/obese premenopausal women (n=120) were randomly assigned to the metformin or placebo group, and all women received lifestyle interventions. The outcomes included weight, BMI, FPG, FIN, glucose, HOMA-IR, LDL-C, HDL-C, TG, TC, SBP, DBP, FSH, E, AD, and the BIRADS grade, and the incidence of breast cancer was assessed by pathological biopsy and BIRADS grade greater than 4.Results: In total, 120 overweight/obese women completed the 1-year trial. Seven patients had a BIRADS grade greater than 4, including 5 patients who were biopsy positive, in the control group, and 2 patients had a BIRADS grade greater than 4, including 1 patient who was biopsy positive, in the metformin group. Compared with those in the control group, the body weight, BMI, FIN, FPG, HOMA-IR, TC, BIRADS grade and positive pathological biopsy rate in the metformin group were significantly decreased (P< 0.05), while AD was significantly increased (P< 0.05). The correlation analysis indicated that the BIRADS grade was significantly correlated with weight, BMI, FPG, FIN, HOMA-IR, SBP, AD and the positive pathological biopsy rate, and the positive pathological biopsy rate was significantly correlated with weight, BMI, HOMA-IR, SBP, AD and BIRADS grade. The logistic regression analysis revealed that the BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD and that the positive pathological biopsy rate was significantly correlated with the BIRADS grade.Conclusion: As adjunctive therapy, the combination of lifestyle changes and metformin was found to be a safe strategy for improving related metabolic markers and increasing adiponectin. The BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD, and the positive pathological biopsy rate was significantly correlated with the BIRADS grade.Keywords: metformin, breast density, overweight/obese, adiponectinLeng WPu DJiang JLei XWu QChen BDove Medical Pressarticlemetforminbreast densityoverweight/obeseadiponectinSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 4423-4432 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	metformin breast density overweight/obese adiponectin Specialties of internal medicine RC581-951
spellingShingle	metformin breast density overweight/obese adiponectin Specialties of internal medicine RC581-951 Leng W Pu D Jiang J Lei X Wu Q Chen B Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
description	Weiling Leng,1 Danlan Pu,2 Juan Jiang,2 Xiaotian Lei,1 Qinan Wu,3,&ast; Bing Chen1,&ast; 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, People’s Republic of China; 3Endocrinology Department, Chongqing Medical University Affiliated Dazu Hospital, Dazu District People’s Hospital, Chongqing, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Qinan Wu; Bing Chen Email wqn11@126.com; chenbingxnyy@126.comBackground: This study investigated the effects of metformin on breast density in overweight/obese premenopausal women.Methods: Overweight/obese premenopausal women (n=120) were randomly assigned to the metformin or placebo group, and all women received lifestyle interventions. The outcomes included weight, BMI, FPG, FIN, glucose, HOMA-IR, LDL-C, HDL-C, TG, TC, SBP, DBP, FSH, E, AD, and the BIRADS grade, and the incidence of breast cancer was assessed by pathological biopsy and BIRADS grade greater than 4.Results: In total, 120 overweight/obese women completed the 1-year trial. Seven patients had a BIRADS grade greater than 4, including 5 patients who were biopsy positive, in the control group, and 2 patients had a BIRADS grade greater than 4, including 1 patient who was biopsy positive, in the metformin group. Compared with those in the control group, the body weight, BMI, FIN, FPG, HOMA-IR, TC, BIRADS grade and positive pathological biopsy rate in the metformin group were significantly decreased (P< 0.05), while AD was significantly increased (P< 0.05). The correlation analysis indicated that the BIRADS grade was significantly correlated with weight, BMI, FPG, FIN, HOMA-IR, SBP, AD and the positive pathological biopsy rate, and the positive pathological biopsy rate was significantly correlated with weight, BMI, HOMA-IR, SBP, AD and BIRADS grade. The logistic regression analysis revealed that the BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD and that the positive pathological biopsy rate was significantly correlated with the BIRADS grade.Conclusion: As adjunctive therapy, the combination of lifestyle changes and metformin was found to be a safe strategy for improving related metabolic markers and increasing adiponectin. The BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD, and the positive pathological biopsy rate was significantly correlated with the BIRADS grade.Keywords: metformin, breast density, overweight/obese, adiponectin
format	article
author	Leng W Pu D Jiang J Lei X Wu Q Chen B
author_facet	Leng W Pu D Jiang J Lei X Wu Q Chen B
author_sort	Leng W
title	Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
title_short	Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
title_full	Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
title_fullStr	Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
title_full_unstemmed	Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
title_sort	effect of metformin on breast density in overweight/obese premenopausal women
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/873a4ff2ab3d4d35a9441fc0d1fe15c6
work_keys_str_mv	AT lengw effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT pud effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT jiangj effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT leix effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT wuq effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT chenb effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen
_version_	1718376335986917376

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women

Ejemplares similares